ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Vinfuture 2025 Honors Four Groundbreaking Scientific Achievements Under The Theme "Rising And Thriving"

HANOI, VIETNAM - Media OutReach Newswire - 5 December 2025 - The VinFuture Foundation officially announces the laureates of the VinFuture Prizes 2025. Four outstanding scientific and technological breakthroughs have been honored, reflecting this year's theme "Rising and Thriving", and highlighting the role of cross-border scientific collaboration in addressing global challenges in health, environment, and human livelihood.

Photo (14).jpg

The 2025 VinFuture Prize Award Ceremony was broadcast live on VTV1, the national television channel of Vietnam. The event was attended by Mr. Tran Thanh Man, Politburo member and Chairman of the National Assembly, along with leaders of central ministries and agencies, representatives of embassies and international organisations, and distinguished scientists from around the world.

The VinFuture Prize 2025 received 1,705 nominations from scientists, research institutions, and technology enterprises worldwide, representing an almost threefold increase relative to the inaugural year. These submissions highlight impactful cross-border research efforts focused on protecting public health, advancing next-generation intelligent materials, addressing climate change, accelerating novel energy solutions, and strengthening global food security frameworks.

The 2025 VinFuture Grand Prize valued at US$3 million is awarded to Dr. Douglas R. Lowy, Dr. John T. Schiller, Dr. Aimée R. Kreimer and Prof. Maura L. Gillison (USA) for discoveries and development of HPV vaccines for prevention of tumors caused by human papillomaviruses.

Foundational studies on HPV capsid proteins by Drs. Douglas Lowy and John Schiller led to the development of highly effective HPV vaccines, preventing millions of cervical cancer cases, especially in developing countries. Furthermore, the single-dose vaccination regimen developed by Dr. Aimée Kreimer – now recommended by the World Health Organization (WHO) – has significantly expanded vaccine access for populations worldwide.

In parallel, laboratory and epidemiological studies by Prof. Maura Gillison and Dr. Aimée Kreimer established the link between HPV and head-and-neck cancers, which represent an emerging cancer threat expected to be mitigated by HPV vaccination efforts. The achievements of Dr. Douglas Lowy, Dr. John Schiller, Dr. Aimée Kreimer, and Prof. Maura Gillison have already saved millions of lives and will keep lowering the global cancer burden for decades to come.

In addition to the Grand Prize, the 2025 VinFuture Prizes will also present three Special Prizes, each valued at US$500,000, recognizing Innovators from Developing Countries, Women Innovators, and Innovators with Outstanding Achievements in Emerging Fields.

The 2025 VinFuture Special Prize for Innovators from Developing Countries​ is awarded to Prof. María Esperanza Martínez-Romero (Mexico) for advances in microbial ecology and symbiotic nitrogen fixation in the tropics. Prof. Martínez-Romero has discovered and described numerous new Rhizobium species, significantly expanding scientific understanding of microbial taxonomy and plant-microbe interactions in agriculture. Her work has opened new directions in the study of bacterial-plant symbiosis, with profound implications for sustainable agriculture in resource-limited settings.

The 2025 VinFuture Special Prize for Women Innovators is awarded to Prof. Mary-Claire King (USA) for identification of the breast and ovarian cancer susceptibility gene BRCA1, laying the foundation for genetic testing, screening programs, and personalized treatment. Her landmark identification of the BRCA1 locus on chromosome 17q21 in 1990, before the human genome was sequenced, is considered a historic milestone, demonstrating the genetic basis of cancer risk and transforming prevention and treatment strategies worldwide.

The 2025 VinFuture Special Prize for Innovators with Outstanding Achievements in Emerging Fields has honored Prof. Venkatesan Sundaresan (USA), Prof. Raphaël Mercier (Germany), Dr. Emmanuel Guiderdoni (France), Dr. Imtiyaz Khanday (USA) and Dr. Delphine Mieulet (France) for innovations in the development of clonal hybrid crops. Hybrid seed production for rice, the staple food for more than half of humankind, is a laborious and costly procedure resulting in a high seed cost. The team's work has enabled rice plants to produce seeds that retain all the superior traits of the parent plant through self-pollination, grounded in new insights into developmental biology and genetics. This groundbreaking research improves yields, reduces seed production costs, and advances sustainable global food security.

Sharing his reflections on this year's honored works, Prof. Sir. Richard Friend, Chair of the VinFuture Prize Council, stated: "The 2025 VinFuture Prize Laureates have made big advances in science that have brought direct benefits to human health and to global sustainable food crop production. From new vaccines and new understanding of genetic susceptibility to disease to new approaches for plant breeding and new protocols for healthy crop growth, these achievements exemplify the power of science driven by compassion and cross-border collaboration - showing that when knowledge serves humanity, it not only deepens our understanding of the world but also strengthens and sustains the very foundations of life itself."

After five consecutive and widely acclaimed award cycles, the VinFuture Prize has been securing recognition among the world's most prestigious science and technology awards, receiving 6,132 nominations from nearly 110 countries and territories across five continents, and honoring 48 outstanding laureates. The awarded innovations—spanning clean energy, artificial intelligence, biomedical technologies, and transformative advances in agriculture—are elevating quality of life, strengthening human well-being, and shaping strategic pathways for the future of humanity.

The VinFuture Prize Ceremony and VinFuture Sci-Tech Week have evolved into an established global platform for scientific exchange, bringing together scientists, policymakers, and business leaders to advance collaborations toward a sustainable, humane, and prosperous future.

Notably, after five award seasons driven by persistent efforts to connect global scientific excellence with the Vietnamese research community, the VinFuture Foundation and the VinFuture Prize have not only fostered new opportunities and momentum for national science, but have also strengthened Vietnam's standing as a trusted destination for the world's scientific community—where innovation is widely shared and amplified for the collective prosperity of humankind.

Launch of the 2026 VinFuture Prize Award Season: The VinFuture Prize 2026 will officially open its nomination portal from 2:00 PM on January 9, 2026, to 2:00 PM on April 17, 2026 (Hanoi time, GMT+7). Nominating partners are invited to submit candidate information through the online nomination portal at: https://vinfutureprize.org/vinfuture-prize-nomination/.



Hashtag: #Vinfuture

The issuer is solely responsible for the content of this announcement.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.56
+0.02 (0.01%)
AAPL  274.61
+0.50 (0.18%)
AMD  209.17
+1.59 (0.77%)
BAC  54.81
-0.52 (-0.94%)
GOOG  307.73
-1.59 (-0.51%)
META  657.15
+9.64 (1.49%)
MSFT  476.39
+1.57 (0.33%)
NVDA  177.72
+1.43 (0.81%)
ORCL  188.65
+3.73 (2.02%)
TSLA  489.88
+14.57 (3.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.